2022 - Research.com Medicine in South Korea Leader Award
Internal medicine, Cardiology, Myocardial infarction, Surgery and Percutaneous coronary intervention are his primary areas of study. In most of his Internal medicine studies, his work intersects topics such as Endocrinology. His study explores the link between Cardiology and topics such as Hazard ratio that cross with problems in Unstable angina.
His Myocardial infarction research integrates issues from Platelet aggregation inhibitor, Ejection fraction, Stroke, Clinical endpoint and Drug. His studies deal with areas such as Meta-analysis, Left Main Coronary Artery Stenosis, Stent thrombosis and Nephropathy as well as Surgery. His Percutaneous coronary intervention research is multidisciplinary, relying on both Thrombolysis, Clinical trial, Conventional PCI and Multicenter trial.
Hyo-Soo Kim mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery. His study on Internal medicine is mostly dedicated to connecting different topics, such as Endocrinology. His work on Revascularization, Clopidogrel, Artery and Angioplasty as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines.
His Myocardial infarction study combines topics in areas such as Diabetes mellitus, Clinical endpoint and Ejection fraction. The study incorporates disciplines such as Conventional PCI and Acute coronary syndrome in addition to Percutaneous coronary intervention. Hyo-Soo Kim studies Randomized controlled trial which is a part of Surgery.
Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI are his primary areas of study. His work on Hazard ratio, Coronary artery disease, Revascularization and Drug-eluting stent as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science. His research in Revascularization intersects with topics in Diabetes mellitus and Cardiogenic shock.
His Myocardial infarction study integrates concerns from other disciplines, such as Stroke, Clinical endpoint and Propensity score matching. His biological study spans a wide range of topics, including Stent, Surgery, Lower risk and Acute coronary syndrome. As part of the same scientific family, Hyo-Soo Kim usually focuses on Conventional PCI, concentrating on Randomized controlled trial and intersecting with Meta-analysis.
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI. All of his Internal medicine and Hazard ratio, Coronary artery disease, Acute coronary syndrome, Prasugrel and Clopidogrel investigations are sub-components of the entire Internal medicine study. His Cardiology research incorporates elements of Stroke, Incidence and Drug.
In Myocardial infarction, Hyo-Soo Kim works on issues like Clinical endpoint, which are connected to Urology. His study in Percutaneous coronary intervention is interdisciplinary in nature, drawing from both Platelet aggregation inhibitor, Stent and ST segment. Hyo-Soo Kim has included themes like Artery, Randomized controlled trial, Intensive care medicine, Pharmacotherapy and Aspirin in his Conventional PCI study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis
Jin Hur;Chang Hwan Yoon;Hyo-Soo Kim;Jin Ho Choi.
Arteriosclerosis, Thrombosis, and Vascular Biology (2004)
Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial
Hyun-Jae Kang;Hyo-Soo Kim;Shu-Ying Zhang;Kyung-Woo Park.
The Lancet (2004)
Diagnosis of Ischemia-Causing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms : Results From the Prospective Multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) Study
Bonkwon Koo;Andrejs Erglis;Joon Hyung Doh;David V. Daniels.
Journal of the American College of Cardiology (2011)
Large-scale association analysis identifies new risk loci for coronary artery disease
Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall.
Nature Genetics (2013)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini;Giuseppe Biondi-Zoccai;Diego Della Riva;Christoph Stettler.
The Lancet (2012)
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.
Chang Hwan Yoon;Jin Hur;Kyung Woo Park;Ji Hyun Kim.
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.
Michael J. Lipinski;Giuseppe G L Biondi-Zoccai;Antonio Abbate;Reena Khianey.
Journal of the American College of Cardiology (2007)
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Hyeon Cheol Gwon;Joo Yong Hahn;Kyung Woo Park;Young Bin Song.
Randomized trial of stents versus bypass surgery for left main coronary artery disease.
Seung Jung Park;Young Hak Kim;Duk Woo Park;Sung Cheol Yun.
The New England Journal of Medicine (2011)
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa;Francesco Costa;Francesco Costa;David van Klaveren;David van Klaveren;Stefan James;Dik Heg.
The Lancet (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: